ConductScience.org, home

Paper38020221

Isolation and characterization of Trichoderma harzianum L-methioninase with promising a powerful anticancer.

Ashkan MF and 2 others. Saudi J Biol Sci, 2023. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Isolation and characterization of Trichoderma harzianum L-methioninase with promising a powerful anticancer. Papers, record 38020221. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38020221

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Isolation and characterization of Trichoderma harzianum L-methioninase with promising a powerful anticancer.
PubMed
Journal
Saudi J Biol Sci
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.1
iCite
Revised in PubMed
2023-12-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ashkan MFMada F
2Younis SASadia A
3Elazab NTNahla T

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15808079Dissimilation of methionine by fungi.J Bacteriol1969https://conductscience.org/library/papers/5808079PubMed
222883554Pharmacokinetics, immunogenicity and anticancer efficiency of Aspergillus flavipes L-methioninase.Enzyme Microb Technol2012https://conductscience.org/library/papers/22883554PubMed
337780Ellman's reagent: 5,5'-dithiobis(2-nitrobenzoic acid)--a reexamination.Anal Biochem1979https://conductscience.org/library/papers/37780PubMed
412367699Immunoenzymometric assay for recombinant methioninase in biological fluids.J Pharm Biomed Anal2002https://conductscience.org/library/papers/12367699PubMed
515328169Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia.Clin Cancer Res2004https://conductscience.org/library/papers/15328169PubMed
620570523Glutamine addiction: a new therapeutic target in cancer.Trends Biochem Sci2010https://conductscience.org/library/papers/20570523PubMed
735093861Methionine Restriction: Ready for Prime Time in the Cancer Clinic?Anticancer Res2022https://conductscience.org/library/papers/35093861PubMed
83843705Measurement of protein using bicinchoninic acid.Anal Biochem1985https://conductscience.org/library/papers/3843705PubMed
926691554Purification, Characterization of L-Methioninase from Candida tropicalis, and Its Application as an Anticancer.Biotechnol Res Int2015https://conductscience.org/library/papers/26691554PubMed
1011560998Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide.J Exp Med2001https://conductscience.org/library/papers/11560998PubMed
1236635695Purification, Characterization and anticancer activity of L-methionine γ-lyase from thermo-tolerant Aspergillus fumigatus.Microb Cell Fact2023https://conductscience.org/library/papers/36635695PubMed
1315574935Identification and functional analysis of the gene encoding methionine-gamma-lyase in Brevibacterium linens.Appl Environ Microbiol2004https://conductscience.org/library/papers/15574935PubMed
1432155163Diversity and antimicrobial activity of endophytic fungi isolated from Securinega suffruticosa in the Yellow River Delta.PLoS One2020https://conductscience.org/library/papers/32155163PubMed
1512920135
Identification and characterization of two isoenzymes of methionine gamma-lyase from Entamoeba histolytica: a key enzyme of sulfur-amino acid degradation in an anaerobic parasitic protist that lacks forward and reverse trans-sulfuration pathways.
J Biol Chem2003https://conductscience.org/library/papers/12920135PubMed
1610825143Methioninase gene therapy of human cancer cells is synergistic with recombinant methioninase treatment.Cancer Res2000https://conductscience.org/library/papers/10825143PubMed
1721369990Purification and characterization of a new L-methioninase from solid cultures of Aspergillus flavipes.J Microbiol2011https://conductscience.org/library/papers/21369990PubMed
1814585259Methionine dependency and cancer treatment.Cancer Treat Rev2003https://conductscience.org/library/papers/14585259PubMed
1933370029Triple-Methyl Blockade With Recombinant Methioninase, Cycloleucine, and Azacitidine Arrests a Pancreatic Cancer Patient-Derived Orthotopic Xenograft Model.Pancreas2021https://conductscience.org/library/papers/33370029PubMed
205432063Cleavage of structural proteins during the assembly of the head of bacteriophage T4.Nature1970https://conductscience.org/library/papers/5432063PubMed
212213904Methionine dependency of malignant tumors: a possible approach for therapy.J Natl Cancer Inst1990https://conductscience.org/library/papers/2213904PubMed

See all 35 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38020221

GET https://conductscience.org/api/papers/v1/38020221/references?page=2